Leap Therapeutics logo
Leap Therapeutics LPTX
$ 2.89 3.96%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Leap Therapeutics EV/EBITDA Ratio 2011-2024 | LPTX

Annual EV/EBITDA Ratio Leap Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.69 -4.46 -1.15 -0.484 -1.2 -2.78 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.484 -4.46 -2.29